A Single Bout of High-Intensity Interval Training Reduces Awareness of Subsequent Hypoglycemia in Patients with Type 1 Diabetes. by Rooijackers, HM et al.
  
 
 
 
 
A single bout of high-intensity interval training reduces 
awareness of subsequent hypoglycemia in patients with 
type 1 diabetes 
 
 
Journal: Diabetes 
Manuscript ID DB16-1535.R2 
Manuscript Type: Original Article: Complications 
Date Submitted by the Author: n/a 
Complete List of Authors: Rooijackers, Hanne; Radboud university medical center, Internal Medicine 
Wiegers, Evita; Radboud university medical center, Radiology and Nuclear 
Medicine 
van der Graaf, Marinette; Radboud university medical center, Radiology 
and Nuclear Medicine; Radboud university medical center, Pediatrics 
Thijssen, Dick; Radboud university medical center, Physiology; Liverpool 
John Moores University, Research Institute for Sport and Exercise Sciences 
Kessels, Roy; Radboud university medical center, Medical Psychology; 
Radboud University, Donders Institute for Brain, Cognition and Behaviour 
Tack, Cees; Radboud university medical center, Internal Medicine 
De Galan, Bastiaan; Radboud university medical center, Internal Medicine 
  
 
 
For Peer Review Only
Diabetes
1 
 
A single bout of high-intensity interval training reduces awareness of 
subsequent hypoglycemia in patients with type 1 diabetes 
 
Running title: Effects of HIIT on awareness of hypoglycemia 
Authors: Hanne M. Rooijackers
1
, Evita C. Wiegers
2
, Marinette van der Graaf
2,3
, Dick H 
Thijssen
4,6
, Roy P.C. Kessels
5,7
, Cees J. Tack
1
, Bastiaan E. de Galan
1
 
Affiliations: Departments of 
1
Internal Medicine, 
2
Radiology and Nuclear Medicine, 
3
Pediatrics, 
4
Physiology, and 
5
Medical Psychology, Radboud university medical center, 
Nijmegen, the Netherlands
 
; 
6
Research Institute for Sport and Exercise Sciences, Liverpool 
John Moores University, Liverpool, United Kingdom ; 
7
Donders Institute for Brain, Cognition 
and Behaviour, Radboud University, Nijmegen, the Netherlands
 
 
 
 
 
 
Corresponding author: 
Hanne M Rooijackers, MD 
Department of Internal Medicine 463 
Radboud university medical center 
PO Box 9101 
6500 HB 
Nijmegen 
the Netherlands 
Tel: +31 24 36 67203 
E-mail: Hanne.Rooijackers@radboudumc.nl 
 
 
 
Word count: 3396 
Word count abstract: 200 
Number of tables: 2 
Number of figures: 5 
2 
 
Abstract 
High-intensity interval training (HIIT) gains increasing popularity in patients with diabetes. 
HIIT acutely increases plasma lactate levels. This may be important, since administration of 
lactate during hypoglycemia suppresses symptoms and counterregulation, whilst preserving 
cognitive function. We tested the hypothesis that HIIT acutely reduces awareness of 
hypoglycemia and attenuates hypoglycemia-induced cognitive dysfunction. In a randomized 
crossover trial, patients with type 1 diabetes and normal awareness of hypoglycemia (NAH), 
patients with impaired awareness of hypoglycemia (IAH), and healthy participants (n=10 per 
group) underwent a hyperinsulinemic-hypoglycemic (2.6 mmol/L) clamp, either after a HIIT 
session or after seated rest. Compared to rest, HIIT reduced symptoms of hypoglycemia in 
patients with NAH, but not in healthy participants or patients with IAH. HIIT attenuated 
hypoglycemia-induced cognitive dysfunction, which was mainly driven by changes in the 
NAH subgroup. HIIT suppressed cortisol and growth hormone responses, but not 
catecholamine responses to hypoglycemia. The present findings demonstrate that a single 
HIIT session rapidly reduces awareness of subsequent hypoglycemia in patients with type 1 
diabetes and NAH, but not in patients with IAH, and attenuates hypoglycemia-induced 
cognitive dysfunction. The role of exercise-induced lactate in mediating these effects, 
potentially serving as an alternative fuel for the brain, should be further explored. 
 
Clinical trial registration number: NCT02308293, ClinicalTrials.gov 
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Introduction 
Regular exercise is recommended for patients with type 1 diabetes as it improves physical 
fitness, insulin sensitivity and general well-being, while reducing cardiovascular risk factors 
(1; 2). High-intensity interval training (HIIT) is a relatively new training modality that 
consists of repeated, brief bouts of exercise at high-intensity (i.e. ≥85% peak oxygen uptake), 
interspersed by periods of rest or low-intensity exercise (3; 4). HIIT is becoming increasingly 
popular, because it has similar or superior training effects compared to endurance training, 
despite lower time commitment (3). In patients with type 1 diabetes, high-intensity (interval) 
training has been reported to exert an acute glucose-stabilizing effect when compared to 
endurance exercise (5-7). Notwithstanding this short-term effect, the risk of late nocturnal 
hypoglycemia after HIIT may be increased (8). It is currently unknown whether HIIT affects 
awareness of subsequent hypoglycemic episodes.  
Performance of HIIT markedly increases plasma lactate levels (9). This is highly relevant, 
since previous studies have demonstrated that the administration of lactate during 
hypoglycemia suppresses counterregulatory hormone responses and hypoglycemic symptoms 
(10-13). In addition, the infusion of lactate also attenuates the decline in cognitive function 
that normally occurs during hypoglycemia (10-13). These effects are presumed to result from 
increased utilization of lactate by the brain (12; 13), which can substitute glucose and act as 
an alternative energy source under hypoglycemic conditions. Elevated levels of endogenous 
lactate induced by HIIT may thus be expected to have similar effects as exogenous lactate, 
and suppress normal physiological responses to subsequent hypoglycemia (i.e. reduced 
counterregulatory hormones, reduced hypoglycemic symptoms and attenuated cognitive 
dysfunction). 
Such a suppressive effect would be particularly worrisome for the ~25% of patients with type 
1 diabetes and impaired awareness of hypoglycemia (IAH), who already have compromised 
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symptomatic and hormonal responses to hypoglycemia (14) and are at high risk of severe 
hypoglycemia (15). In these patients high levels of endogenous lactate after HIIT might even 
further impair counterregulation. Therefore, the aim of the present study was to investigate the 
effect of HIIT on hypoglycemic symptoms, counterregulatory hormone responses and 
cognitive function during subsequent hypoglycemia in patients with type 1 diabetes and 
normal awareness of hypoglycemia (NAH) and impaired awareness of hypoglycemia (IAH), 
but also in healthy participants.  
  
Research design and methods 
Participants 
We recruited ten non-diabetic participants, ten type 1 diabetes patients with NAH, and ten 
type 1 diabetes patients with IAH. Patients with type 1 diabetes were eligible if they had an 
HbA1c below 9.0% (75 mmol/mol) and were free from macro- and microvascular  
complications, except for background retinopathy. Exclusion criteria included a history of 
cardiopulmonary disease, anxiety disorders, brain injury, age > 40 years, and the use of drugs 
other than insulin interfering with glucose metabolism. Awareness state was first assessed by 
a Dutch version of the Clarke questionnaire (16; 17), but final stratification was based on 
adrenaline and symptomatic responses to the hypoglycemic clamps. Eighteen out of twenty 
patients were rightly characterized as having IAH or NAH by the Clarke questionnaire. One 
patient initially classified as having intact awareness (NAH) had very low adrenaline and 
symptom responses to the hypoglycemic clamp, whereas another patient presumably with 
impaired awareness displayed normal responses to the clamp. The latter two patients switched 
groups. All participants were recreationally active. The institutional review board of the 
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Radboud university medical center approved the study and all study participants gave written 
informed consent before participation. 
 
Experimental design 
In a random order, all enrolled participants underwent two hyperinsulinemic-hypoglycemic 
glucose clamp (nadir, 2.6 mmol/L) experiments, one that was preceded by a HIIT session and 
one preceded by seated rest (duration equivalent of HIIT session). The two experiments were 
scheduled at least two weeks apart, except in the women participating, in whom experiments 
were conducted during similar phases of the menstrual cycle.  
 
Participants presented between 8.00 and 8.30 AM at the clinical research facility after an 
overnight fast, having abstained from caffeine, alcohol and smoking for 24h, and from 
strenuous exercise for two days. Participants with diabetes received specific instructions to 
avoid (nocturnal) hypoglycemia the day before the clamp. Experiments were rescheduled in 
cases of hypoglycemia in the 24 hours before the clamp. Upon arrival, intravenous cannulae 
were inserted into the antecubital veins of both forearms. One forearm was placed in a heated 
box (55°C), so that arterialized venous blood could be obtained for frequent blood sampling. 
The cannula in the contralateral arm was used for infusion of glucose 20% (Baxter B.V., 
Deerfield, IL) and insulin (insulin aspart; Novo Nordisk, Bagsvaerd, Denmark). Baseline 
plasma glucose and lactate levels were determined (Biosen C-Line, EKF Diagnostics, Cardiff, 
UK) and hyperglycemia in patients with diabetes was corrected as needed with a small bolus 
of insulin. Subsequently, a two-step hyperinsulinemic (60 mU/m
2
/min) euglycemic (5.0 
mmol/L)-hypoglycemic (2.6mmol/L) glucose clamp was initiated. Plasma glucose and lactate 
values were determined every five minutes. Blood samples for measurement of 
catecholamines and cortisol were taken at euglycemia, 5 minutes after exercise, and at 20-
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minute intervals during hypoglycemia. Insulin, glucagon, growth hormone (GH) and pH were 
measured at euglycemia, after exercise (only GH and pH) and at the end of hypoglycemia. 
Under clamped, euglycemic conditions, participants performed HIIT or rested for the same 
period of time. Subsequently, plasma glucose levels were allowed to fall to 2.6 mmol/l over 
~35 minutes and were maintained there for another 60 minutes.  
 
Exercise protocol 
The HIIT session was performed on a cycle ergometer (Lode Corival, Procare, Groningen, 
The Netherlands) and had a total duration of approximately 15 minutes. Prior to the start, a 
short 10-second test sprint was performed to determine optimal resistance of the ergometer 
(equaling ~0.1kg/kg body mass, depending on the participant's physical activity level and 
cycling experience). The exercise protocol consisted of a 4-minute warm-up at 50 Watt (W), 
followed by three 30-second all-out sprints during which participants had to cycle as fast as 
possible, interspersed with 4 minutes active recovery (50W). The resistance applied during 
the all-out sprints was adjusted depending on the perceived intensity of the previous sprint, 
measured with the Borg scale (18), aiming at a Borg score >15 (running from 6, indicating no 
exertion to 20, indicating maximal exertion). The scale was displayed in front of the 
participants while exercising and after each all-out sprint, participants selected the number 
that best described their perceived level of exertion.  
 
Symptom scores 
Participants were asked to complete a semiquantitative symptom questionnaire at euglycemia, 
and at 20, 40 and 60 minutes of hypoglycemia. Symptoms were scored from 0 (none) to 6 
(severe) and included six autonomic (trembling, palpitations, anxiety, sweating, hunger, 
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tingling), six neuroglycopenic (blurred vision, difficulty speaking, feeling faint, difficulty 
thinking, fatigue, confused), four general (dry mouth, weakness, nausea, headache) and two 
dummy symptoms (yellow vision, pain in the legs). Total symptom scores (i.e. scores 
including all symptom subcategories) and subscores were averaged over the three time points 
(after 20, 40 and 60 minutes of hypoglycemia). Peak symptom scores were defined as the 
highest total symptom score during hypoglycemia, irrespective of the time point. 
 
Cognitive function tests 
The following cognitive function tests were applied during the screening visit and during 
hypoglycemia, starting 15 minutes after hypoglycemia was reached. In cases of hypoglycemia 
(n=2) or hyperglycemia (n=1) during the screening visit, the first battery of cognitive function 
tests was applied during the euglycemic phase of the first test day. Non-specific practice 
effects were controlled for by counterbalancing the order of the rest and HIIT intervention, 
and parallel forms were used to avoid material-specific practice effects if applicable. 
Digit span forward and backward. Subtest of the Dutch version of the Wechsler Adult 
Intelligence Scale (WAIS)-III that measures attention and working memory (19). Sequences 
of digits of increasing lengths were presented verbally and participants were asked to recall 
the digits in the presented and in the reverse order. 
Verbal fluency test. Dutch version of the Controlled Oral Word Association Test (COWAT) 
that serves as an index of executive function (20). Participants were given 1 minute to name 
as many words as possible starting with a given letter. Parallel sets of letter triads (D-A-T, K-
O-M, and P-G-R) were used for baseline, HIIT and rest measurements. 
Paced Auditory Serial Addition Test (PASAT). Evaluates speed of information processing, 
divided and sustained attention (21). Continuous sequences of 61 digits are auditorily 
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presented and participants are asked to add each new digit to the one immediately prior to it 
and say the answer out loud. Sequences were presented at three rates of presentation, i.e. 
every 2.4, 2.0 or 1.6 seconds. 
In order to provide a composite score of cognitive function, raw scores of each test were 
transformed into Z-scores, based on the distribution of test scores at baseline (including all 
three study groups), and were averaged (22). 
 
Analytical methods 
Plasma insulin was assessed by an in-house radioimmunoassay (RIA) (23). After extraction 
(24), plasma glucagon was measured by RIA with a commercially available kit 
(Eurodiagnostica, Malmö, Sweden). Plasma GH and cortisol were determined using a routine 
analysis method with an Electrochemiluminescent Immunoassay on a Modular Analytics 
E170 (Roche Diagnostics, GmbH, Manheim, Germany). Plasma adrenaline and noradrenaline 
were analyzed by HPLC combined with fluorometric detection (25). pH was measured by 
routine venous blood gas analysis in lithium heparin-anticoagulated blood immediately after 
withdrawal, using CG4+ cartridges and an i-STAT blood gas analyzer (Abbott, Libertyville, 
IL, USA).  
 
Statistical analysis 
Data were tested for normality using the Shapiro-Wilk test and QQ-plots. Differences in 
means within groups were analyzed with paired Student’s t-tests or Wilcoxon’s signed rank 
test when data were not normally distributed. Differences in means between groups were 
analyzed by ANOVA followed by Bonferroni’s post hoc tests to delineate statistical 
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significance, and for non-parametric data with the Kruskal-Wallis test and post hoc Mann-
Whitney U tests. Serial data (hormone responses and glucose infusion rates) were analyzed by 
two-way repeated measures ANOVA, in which missing data were replaced with the last 
observed value. The cognitive tests were analyzed with a repeated measures general linear 
model ANOVA with study group (healthy controls, patients with NAH or patients with IAH) 
as a between-subject factor and intervention (HIIT or rest) as a within-subject factor, followed 
by post hoc paired Student’s t-tests. All data are expressed as mean ± standard error of the 
mean (SEM), unless otherwise specified. Alpha was set at 0.05 throughout. Statistical 
analyses were performed with IBM SPSS Statistics 20. 
 
Results 
The three groups of participants were well matched for age, sex and BMI (Table 1). Diabetes 
duration did not differ significantly between the two diabetes groups, HbA1c was borderline 
significantly lower in patients with IAH compared to those with NAH (p=0.05). Glucose 
levels during the clamps are shown in figure 1A and B.  
Physiological effects of exercise 
Average workload during all-out sprints for the whole study population was 437±17 W and 
mean perceived exertion was 16±0.4 on the Borg scale, with no difference between groups. 
HIIT markedly increased plasma lactate levels from 1.2±0.1 to 13.1±0.5 mmol/L (Fig. 1D) 
and decreased pH from 7.36±0.00 to 7.19±0.01 to a similar extent in all groups. After 
reaching peak levels, plasma lactate levels fell gradually, but remained well above baseline 
levels during the subsequent hypoglycemic clamp in both patient groups and for 40 minutes 
of hypoglycemia in healthy participants. Immediately after HIIT, plasma glucose levels 
increased slightly in all three groups, but remained within the normoglycemic range (Fig. 1B). 
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HIIT increased plasma levels of adrenaline by 0.11±0.04 nmol/L, noradrenaline by 4.1±0.4 
nmol/L and GH by 14±4.7 mU/L (p all <0.05), whereas plasma cortisol levels tended to 
increase (mean increase 0.04±0.02 µmol/L, p=0.06). Hormonal responses to exercise were 
similar between all groups. All hormone levels returned to levels indistinguishable from those 
at rest days prior to the beginning of hypoglycemia (approximately 40 minutes after exercise), 
with the exception of plasma cortisol, which remained slightly elevated in diabetes patients 
with IAH.  
 
Responses to hypoglycemia after HIIT or rest 
Hypoglycemic symptoms. Compared to seated rest, HIIT reduced mean total hypoglycemic 
symptom scores (p=0.01, Fig. 2) and peak symptom scores in patients with type 1 diabetes 
and NAH (p=0.04, Table 2). These decreases were mainly due to reduced neurogenic and 
general symptom responses (p=0.008 and p=0.04, Table 2). In healthy participants, HIIT 
numerically decreased all symptom categories, but this failed to reach statistical significance 
(p=0.19, Fig. 2, Table 2). On both test days, diabetes patients with IAH had the lowest 
hypoglycemic symptom scores compared to the other two groups; their scores were not 
affected by prior HIIT (p=0.80, Fig.2, Table 2).  
Counterregulatory hormones and glucose infusion rate. HIIT did not affect plasma 
adrenaline or noradrenaline responses to hypoglycemia in either subgroup (Fig. 3A-F). 
Plasma levels of glucagon increased to a similar extent in response to hypoglycemia on both 
test days in healthy participants, but – as expected – did not change on either day in the two 
patient groups (data not shown). HIIT suppressed the plasma cortisol response to 
hypoglycemia in healthy participants and patients with NAH (Fig. 3G-I) and suppressed the 
plasma GH responses in all groups (Fig. 4A-C). Glucose infusion rates during hypoglycemia 
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were not different between HIIT and rest days in any group (5.6±0.5 versus 4.8±1.0 mg·kg
-
1
·min
-1
, 4.4±0.6 versus 3.7±0.7 mg·kg
-1
·min
-1
, and 4.4±0.4 versus 4.6±0.4 mg·kg
-1
·min
-1
 for 
healthy participants, patients with NAH, and patients with IAH, respectively). The plasma 
adrenaline response to hypoglycemia was significantly lower in patients with IAH compared 
to patients with NAH and healthy participants, on both study days (p<0.005, Fig. 3A-C). 
Cognitive function. All three subgroups performed worse on cognitive tests during 
hypoglycemia compared to the screening visit, with mean decreases in Z-scores of 0.6±0.1 
and 0.9±0.1 on the HIIT and rest day, respectively (all p<0.05, Fig. 5). Hypoglycemia-
induced cognitive dysfunction was less pronounced after prior HIIT than after prior rest (main 
effect of intervention, p=0.01). There was no significant interaction effect (timepoint x study 
group, p=0.27). Post hoc analysis revealed that the attenuating effect of HIIT on 
hypoglycemia-induced cognitive deterioration was only significant in patients with diabetes 
and NAH (p<0.05), but did not reach significance in the other two subgroups (p=0.11 for 
healthy participants and p=0.46 for patients with IAH).  
 
Discussion  
The main finding of the present study is that a bout of high-intensity interval training 
suppresses symptoms of subsequent hypoglycemia in patients with type 1 diabetes and NAH. 
HIIT also causes less hypoglycemia-induced cognitive deterioration, an effect that was mainly 
driven by the NAH patient subgroup. HIIT did not affect hypoglycemic awareness in patients 
with IAH, likely because of a ‘floor’ effect in that symptom reponses could not be further 
suppressed than they already were. In healthy participants, HIIT numerically decreased 
symptoms of hypoglycemia, but this failed to reach statistical significance. These data 
demonstrate that one short HIIT session is able to rapidly blunt hormonal and symptomatic 
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defenses against hypoglycemia in patients with NAH, which may increase the risk of post-
exercise hypoglycemia.  
 
Our findings of the suppressive effect of antecedent HIIT on defenses against hypoglycemia 
extend those of other exercise studies (26-29). However, there is substantial variation in the 
specific counterregulatory responses that are affected by antecedent exercise. Antecendent 
low- to moderate- intensity exercise (at 30 and 50% peak oxygen uptake) has been shown to 
cause a universal suppression of hormonal and symptomatic responses to next-day 
hypoglycemia (28). Remarkably, two bouts of more vigorous exercise (~70%  peak oxygen 
uptake) had limited effects, in that only adrenaline responses to subsequent hypoglycemia 
were attenuated (27). We now demonstrate that an even more intensive exercise test causes 
blunting of symptomatic, cortisol and GH responses to subsequent hypoglycemia, but not of 
catecholamine responses. Similar defects in counterregulatory hormones were observed in 
antecedent hypoglycemia studies in which the interval between the stimulus and subsequent 
hypoglycemia was relatively short (30; 31). Taken together, it appears that antecedent 
exercise, similar to antecedent hypoglycemia, is able to induce a range of counterregulatory 
defects, the magnitude and components of which seem to depend on the particular exercise 
protocol used (e.g. exercise intensity, duration) and the timeframe between exercise and 
subsequent hypoglycemia.    
 
The mechanisms underlying exercise-induced attenuation of counterregulatory hormone and 
symptom responses are currently not known. We hypothesize that elevated lactate levels in 
response to HIIT mediate a suppressive effect. High plasma lactate levels lead to an increase 
in brain lactate utilization, both after intravenous administration (32) and after vigorous 
exercise (33; 34). An increase in brain lactate oxidation during hypoglycemia has been 
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suggested to preserve brain metabolism (10; 12). This may prevent hypoglycemia-induced 
cognitive dysfunction, since the brain is no longer deprived of fuel. Maintenance of brain 
metabolism may simultaneously impede hypoglycemia sensing by the brain and thus suppress 
the consequent initiation of protective counterregulatory and symptom responses (35). 
Previous work found that administration of exogenous lactate during hypoglycemia 
suppresses symptoms and hormone responses, while preserving cognitive function, thus 
mimicking the situation seen in patients with IAH (10-13). In these patients, several cerebral 
adaptations have been observed during hypoglycemia, including increased capacity to use 
lactate (35-38). Alternatively, lactate may act as a metabolic regulator in the brain rather than 
as a fuel per se (39; 40).  
 
Several arguments support a role for elevated lactate levels in the suppression of physiological 
responses to hypoglycemia after HIIT. First, we showed that the deterioration of cognitive 
function during hypoglycemia was less after HIIT than rest, which is in accordance with 
previous studies that infused lactate during hypoglycemia (10; 12). In addition, a recent 
exercise study found that higher lactate levels after HIIT were associated with better executive 
function during post-exercise recovery, under euglycemic conditions (41). We also observed 
fast suppression of hypoglycemic symptoms, cortisol and growth hormone responses after 
HIIT (i.e. less than 1 h after the initial stimulus). Whereas central nervous system adaptations 
to hypoglycemia are thought to take hours to days to become manifest (42), the suppressive 
effects of lactate are known to occur rapidly and probably do not involve an adaptation 
process (13). Interestingly, blunting of symptoms was most pronounced in participants with 
the highest symptom scores. Changes in symptoms were not correlated to changes in 
adrenaline responses. Increased capacity to transport lactate over the blood-brain barrier in 
patients with type 1 diabetes (as a result of prior exposure to hypoglycemia) may in part 
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explain differential effects of HIIT in patients with NAH and healthy controls (43). However, 
quantitative comparisons with studies using exogenous lactate during hypoglycemia need to 
acknowledge the influence of exercise itself, pH differences and the duration and stability of 
plasma lactate elevations. 
 
Habituation of the brain in response to recurrent hypoglycemia is thought to underlie the 
development of IAH (44) and restoration of IAH can be achieved by scrupulous avoidance of 
hypoglycemia (45; 46). It has recently been speculated that ‘re-sensitizing’ the brain to 
hypoglycemia might also be achieved by exposition to high-intensity exercise as a novel 
stimulus in an animal model of IAH (47). In this model, antecedent hypoglycemia-induced 
defects in glucose counterregulation were restored 24 hours after a bout of high-intensity 
exercise. This differs from our findings, in that we observed no improvements in 
counterregulatory responses to hypoglycemia after HIIT in patients with type 1 diabetes and 
IAH. However, differences in species and study design, particularly the timeframe between 
exercise and hypoglycemia, should be acknowledged when explaining these seemingly 
contradictory results.  
 
Our study design differed from most studies that addressed the impact of antecedent exercise 
on defenses against hypoglycemia, since the timeframe between exercise and hypoglycemia 
was short. This approach was chosen because we wanted to assess the effect of high 
endogenous plasma lactate levels during hypoglycemia, in view of the known effects of 
exogenous lactate during hypoglycemia. While we provide arguments for increased lactate 
levels as an explanation for the suppression of awareness of hypoglycemia and attenuation of 
cognitive dysfunction, our studies can not prove a cause and effect relationship. Although less 
likely, other mechanisms than lactate may explain the acute beneficial effects of HIIT on 
cognition, including increased arousal (48; 49). Participants could not be blinded for the 
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intervention (HIIT vs. rest): while unlikely, some influence of participant expectations on the 
results cannot be excluded. Strengths of our study include the randomized, cross-over design 
that allowed us to compare responses to HIIT and rest in the same participants, under similar 
conditions.  
 
In conclusion, a short bout of high-intensity interval exercise suppresses symptoms of 
subsequent hypoglycemia in patients with type 1 diabetes, but does not affect awareness in 
patients with IAH. The role of exercise-induced lactate in mediating the suppressive effects of 
HIIT on hypoglycemic awareness should be further explored. Reduced symptomatic 
responses may increase the risk of hypoglycemia after intensive exercise.  
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Tables 
Table 1: Participant characteristics  
 Healthy controls T1DM-NAH T1DM-IAH 
Age, yrs 25.2±5.5 (19-37)  23.9±4.4 (19-34)  25.7±5.8 (19-35)  
Sex, M:F 5:5  4:6  5:5  
BMI, kg/m
2
 22.5±1.8  23.0±2.3  23.4±1 .4  
Exercise, hours/week 3.7±2.2  4.3±2.9  4.9±3.7  
Score on modified Cox 
questionnaire (range) 
-  0.8±1.3 (0-4) 3.7±1.3 (1-5) 
HbA1C, % (mmol/mol) - 7.5±0.6 (59.0±6.9)  6.9±0.7 (52.1±7.7)  
Duration of diabetes, yrs -  10.7±4.5  13.9±8.1  
Insulin dose, Units/kg/day 
(range) 
- 0.7±0.4 (0.4-0.9) 0.6±0.4 (0.4-0.8) 
Insulin regimen, n 
Multi-injection therapy 
Pump therapy 
-  
5 
5 
 
2 
8 
Data are presented as number or means ± SD. Abbreviations: T1DM, type 1 diabetes; NAH, normal 
awareness of hypoglycemia; IAH, impaired awareness of hypoglycemia; BMI, body-mass index. 
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Table 2. Symptom scores during hypoglycemia 
 Healthy controls T1DM-NAH T1DM-IAH 
Rest HIIT Rest HIIT Rest HIIT 
Peak  20.3 ± 3.5† 17.8 ± 2.7 31.1 ± 5.6† 21.9 ± 3.9*† 10.5 ± 1.6 10.9 ± 2.0 
Neurogenic  7.7 ± 1.4† 6.6 ± 0.9† 10.9 ± 2.0† 7.0 ± 1.6* 3.3 ± 0.5 3.3 ± 0.6 
Neuroglycopenic  5.6 ± 1.4† 4.3 ± 1.1 9.2 ± 1.8† 6.7 ± 1.3† 2.9 ± 0.5 3.0 ± 0.6 
General  3.5 ± 0.9† 3.3 ± 0.7 5.2 ± 0.9† 3.8 ± 0.7*† 1.1 ± 0.3 1.6 ± 0.5 
Peak scores represent the highest total symptom score during hypoglycemia (±SEM), irrespective of 
the time point. All other symptom scores were averaged over the three time points (after 20, 40 and 60 
minutes of hypoglycemia, mean ± SEM),*p<0.05 for HIIT vs. Rest, †p<0.05 versus T1DM-IAH. 
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Figure legends 
Figure 1: Time courses of plasma glucose (A, B) and plasma lactate (C, D) during the rest 
day (left panel) or HIIT day (right panel). Dashed lines represent the beginning and end of the 
euglycemic phase, and the beginning of the hypoglycemic phase, respectively. During the 
euglycemic phase, participants performed HIIT or rested. Baseline values represent the first 
sample obtained upon arrival. Open circles, healthy controls; black squares, patients with type 
1 diabetes (T1DM) and NAH (T1DM-NAH); black triangles, patients with IAH (T1DM-
IAH).  
Figure 2: Average total hypoglycemic symptom scores. Average individual (individual dots) 
and average group total symptom scores (gray bars) during hypoglycemia after prior HIIT or 
seated rest in healthy controls (A), T1DM-NAH (B) and T1DM-IAH (C). Symptom scores 
after 20, 40 and 60 minutes of hypoglycemia were averaged to provide one composite score.  
Figure 3: Adrenaline, noradrenaline and cortisol responses to hypoglycemia after prior rest 
(open circles) or prior HIIT (black squares) in healthy controls (left), T1DM-NAH (middle) 
and T1DM-IAH (right). Eu denotes euglycemia, Hypo denotes hypoglycemia.  
Figure 4: Growth hormone responses to hypoglycemia after prior rest (open bars) or prior 
HIIT (black bars) in healthy controls (left), T1DM-NAH (middle) and T1DM-IAH (right). Eu 
denotes euglycemia, Hypo denotes hypoglycemia, *p<0.05. 
Figure 5: Hypoglycemia-induced change in cognitive function after seated rest (open bars) or 
HIIT (closed bars). Mean (with SEM) differences in Z-scores between the screening visit and 
hypoglycemia are depicted, *p<0.05.  
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